Cwm LLC Sells 2,698 Shares of Phibro Animal Health Corporation (NASDAQ:PAHC)

Cwm LLC lessened its stake in Phibro Animal Health Corporation (NASDAQ:PAHC) by 33.2% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 5,423 shares of the company’s stock after selling 2,698 shares during the quarter. Cwm LLC’s holdings in Phibro Animal Health were worth $116,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of PAHC. Point72 Asia Singapore Pte. Ltd. bought a new stake in Phibro Animal Health during the 4th quarter valued at $29,000. Lazard Asset Management LLC raised its holdings in Phibro Animal Health by 2,739.7% during the 4th quarter. Lazard Asset Management LLC now owns 1,647 shares of the company’s stock valued at $34,000 after acquiring an additional 1,589 shares during the period. Virtus Fund Advisers LLC bought a new stake in Phibro Animal Health during the 4th quarter valued at $69,000. Aquatic Capital Management LLC bought a new stake in Phibro Animal Health during the 4th quarter valued at $69,000. Finally, Meeder Asset Management Inc. bought a new stake in Phibro Animal Health during the 4th quarter valued at $113,000. Institutional investors own 99.34% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently commented on PAHC shares. JPMorgan Chase & Co. upgraded shares of Phibro Animal Health from a “neutral” rating to an “overweight” rating and boosted their price target for the company from $25.00 to $35.00 in a research report on Monday, July 7th. Wall Street Zen raised shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a report on Friday, May 9th. BNP Paribas Exane raised shares of Phibro Animal Health from an “underperform” rating to a “neutral” rating and set a $24.00 price target on the stock in a report on Monday, June 16th. Morgan Stanley set a $26.00 price target on shares of Phibro Animal Health and gave the stock an “equal weight” rating in a report on Wednesday, June 25th. Finally, BNP Paribas raised shares of Phibro Animal Health to a “hold” rating in a report on Monday, June 16th. Two analysts have rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $24.40.

Phibro Animal Health Stock Down 0.3%

Shares of NASDAQ:PAHC opened at $27.92 on Thursday. Phibro Animal Health Corporation has a 52-week low of $16.16 and a 52-week high of $31.80. The firm has a fifty day moving average of $26.57 and a 200 day moving average of $23.20. The firm has a market capitalization of $1.13 billion, a PE ratio of 35.80, a price-to-earnings-growth ratio of 0.47 and a beta of 0.75. The company has a debt-to-equity ratio of 2.67, a quick ratio of 1.23 and a current ratio of 2.91.

Phibro Animal Health (NASDAQ:PAHC) last announced its earnings results on Wednesday, May 7th. The company reported $0.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.52 by $0.11. Phibro Animal Health had a net margin of 2.68% and a return on equity of 30.51%. The company had revenue of $347.80 million during the quarter, compared to analyst estimates of $352.41 million. As a group, research analysts anticipate that Phibro Animal Health Corporation will post 1.95 EPS for the current fiscal year.

Phibro Animal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 24th. Investors of record on Wednesday, September 3rd will be given a $0.12 dividend. The ex-dividend date is Wednesday, September 3rd. This represents a $0.48 annualized dividend and a yield of 1.72%. Phibro Animal Health’s dividend payout ratio (DPR) is presently 61.54%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.